Annexes to COM(2023)2 - EU position on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961

Please note

This page contains a limited version of this dossier in the EU Monitor.

Annex to the Framework Decision.
(7) For more information on the implications of intensive monitoring, see https://www.emcdda.europa.eu/system/files/publications/12213/downloads/Guidance%20Note%206-%20Intensive%20monitoring.pdf .
(8) With one single exception which is the object of an ongoing infringement procedure.
(9) Judgment of the Court of Justice of 7 October 2014, Germany v Council, C-399/12, ECLI:EU:C:2014:2258, paragraph 64.
(10) Judgment of the Court of Justice of 7 October 2014, Germany v Council, C-399/12, ECLI:EU:C:2014:2258, paragraphs 61 to 64.
(11) Article 3(7) of the Convention on Narcotic Drugs; Article 2(7) of the Convention on Psychotropic Substances.
(12) United Nations Treaty Series, vol. 978, No. 14152.
(13) United Nations Treaty Series, vol. 1019, No. 14956.
(14) Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking (OJ L 335, 11.11.2004, p. 8).
(15) Austria, Belgium, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, Slovenia, Spain, and Sweden.
(16) https://cdn.who.int/media/docs/default-source/controlled-substances/45th-ecdd/45th-ecdd-unsg-letter.pdf?sfvrsn=27124af4_3
(17) Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (OJ L 376, 27.12.2006, p. 1).
(18) Commission Delegated Directive (EU) 2022/1326 of 18 March 2022 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of ‘drug’ (OJ L 200, 29.7.2022, p. 148).